The FDA’s transition to the Quality Management System Regulation (QMSR) has fundamentally changed how medical device manufacturers are inspected. Understanding what to expect during an FDA inspection under the QMSR framework is essential for preparation and success. The New Inspection Approach With the QMSR in effect, the FDA retired the Quality System Inspection Technique (QSIT) that had been used…
A QMSR gap analysis is one of the most important steps medical device manufacturers can take to ensure compliance with the FDA’s Quality Management System Regulation. By systematically comparing your current quality system against QMSR requirements, you can identify deficiencies before they become regulatory findings during an FDA inspection. Understanding the QMSR Gap Analysis A gap analysis is a…
With the FDA QMSR now in effect, conducting a thorough readiness assessment is critical for medical device manufacturers who want to ensure their quality systems meet the new regulatory requirements. A QMSR readiness assessment goes beyond a simple documentation review — it evaluates whether your organization’s quality management system is fully aligned with the combined requirements of ISO 13485:2016…
The FDA’s Quality Management System Regulation became effective on February 2, 2026, marking the end of a two-year transition period and the beginning of a new era in medical device quality regulation. Understanding the timeline, current requirements, and what to expect going forward is essential for every medical device manufacturer. The QMSR Timeline The journey to QMSR began years…
With the FDA QMSR now in effect as of February 2, 2026, medical device manufacturers face a new regulatory reality. Compliance is no longer optional, and the FDA has already begun conducting inspections under the new framework. Here is what you need to know to ensure your organization is prepared. The Compliance Deadline Has Passed Unlike some regulatory transitions…
The FDA Quality Management System Regulation (QMSR) represents the most significant change to medical device quality system requirements in the United States in decades. Effective February 2, 2026, the QMSR replaces the legacy Quality System Regulation (QSR) under 21 CFR Part 820 by incorporating ISO 13485:2016 by reference. What Is the QMSR? The QMSR is the FDA’s effort to…
Supplier quality is one of the most critical — and often underestimated — factors in maintaining product quality and regulatory compliance. For organizations in medical devices, diagnostics, and aerospace, the performance of your supply chain directly impacts patient safety, product reliability, and regulatory standing. Why Supplier Audits Are Essential Regulatory frameworks such as ISO 13485 and FDA QMSR require…
Internal audits are a fundamental component of any quality management system. Whether required by ISO 13485, ISO 9001, or customer-specific expectations, internal audits provide a structured opportunity to evaluate how well your quality system is performing in practice — not just on paper. Why Internal Audits Matter Internal audits serve multiple purposes within a regulated organization: Compliance verification: Confirming…
The FDA’s transition from the Quality System Regulation (QSR) under 21 CFR Part 820 to the Quality Management System Regulation (QMSR), which aligns with ISO 13485:2016, represents one of the most significant regulatory shifts for medical device manufacturers in recent years. What Is Changing? The QMSR replaces the prescriptive requirements of 21 CFR Part 820 with a framework that…
Qualyx Group provides independent, audit-only services for organizations operating in highly regulated environments, including medical devices, diagnostics, and aerospace. Our audits are conducted with OEM-grade rigor, objectivity, and a risk-based focus — without consulting, implementation, or conflicts of interest.
We work with organizations operating in highly regulated environments to provide independent, audit-only services. A free initial consultation is available.
(239) 677-5467
